Strasbourg, January 7, 2025 – 06:00 pm CET
Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2024, the following resources were managed through the liquidity account:
In the second half of 2024, a total of:
Purchases | 250,777 shares | € 243,947.38 | 1,154 market transactions |
Sales | 229 905 shares | € 230,275.17 | 1,081 market transactions |
It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:
At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
Contacts
Transgene: Lucie LARGUIER CFO +33 (0)3 88 27 91 00 investorrelations@transgene.fr |
Attachment
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.